Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dougados

Showing results (321-330 of 362) with videos related to

Pageof 37
Sort By:
Annals of the Rheumatic Diseases|May 10, 2005
EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritisM A D'Agostino, P Conaghan, M Le Bars, et al.
Rheumatology (Oxford, England)|February 16, 2008
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologistsP I Sidiropoulos, G Hatemi, I-H Song, et al.
RMD Open|October 29, 2015
Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registryJ H Salmon, P Cacoub, B Combe, et al.
Osteoarthritis and Cartilage|February 19, 2008
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelinesW Zhang, R W Moskowitz, G Nuki, et al.
Osteoarthritis and Cartilage|August 28, 2007
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidenceW Zhang, R W Moskowitz, G Nuki, et al.
Annals of the Rheumatic Diseases|May 23, 2012
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registryJ E Gottenberg, P Ravaud, A Cantagrel, et al.
Rheumatology (Oxford, England)|September 29, 1999
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2P Brooks, P Emery, J F Evans, et al.
Osteoarthritis and Cartilage|February 23, 2010
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009W Zhang, G Nuki, R W Moskowitz, et al.
Annals of the Rheumatic Diseases|January 17, 2009
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)J Sieper, D van der Heijde, R Landewé, et al.
Annals of the Rheumatic Diseases|September 14, 2006
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitisD van der Heijde, J C Da Silva, M Dougados, et al.
Pageof 37

Showing results (321-330 of 362) with videos related to

Sort By:
Pageof 37
Annals of the Rheumatic Diseases|May 10, 2005
EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritisM A D'Agostino, P Conaghan, M Le Bars, et al.
Rheumatology (Oxford, England)|February 16, 2008
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologistsP I Sidiropoulos, G Hatemi, I-H Song, et al.
RMD Open|October 29, 2015
Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registryJ H Salmon, P Cacoub, B Combe, et al.
Osteoarthritis and Cartilage|February 19, 2008
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelinesW Zhang, R W Moskowitz, G Nuki, et al.
Osteoarthritis and Cartilage|August 28, 2007
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidenceW Zhang, R W Moskowitz, G Nuki, et al.
Annals of the Rheumatic Diseases|May 23, 2012
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registryJ E Gottenberg, P Ravaud, A Cantagrel, et al.
Rheumatology (Oxford, England)|September 29, 1999
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2P Brooks, P Emery, J F Evans, et al.
Osteoarthritis and Cartilage|February 23, 2010
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009W Zhang, G Nuki, R W Moskowitz, et al.
Annals of the Rheumatic Diseases|January 17, 2009
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)J Sieper, D van der Heijde, R Landewé, et al.
Annals of the Rheumatic Diseases|September 14, 2006
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitisD van der Heijde, J C Da Silva, M Dougados, et al.
Pageof 37